May 30, 2024
In the News
April 24, 2024
Cell & Gene: NK Cell Therapies – How Artiva Biotherapeutics Leverages Its “Manufacturing First” Approach
March 1, 2024
BiotechTV: Using NK Cell Therapies for Autoimmune Disease and Cancer with Artiva’s CEO
March 1, 2024
Clinical Trials Arena: Artiva Prepares to Kick off Phase I/II Trial for NK Cell Therapy
February 21, 2024
GEN: Easier Access to NK-Based Cell Therapies
December 14, 2023
Artiva Named a PM360 2023 Innovative Startup
November 2, 2023